Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brozopentyl sodium dose-ranging trial in acute ischemic stroke
ChiCTR1900028334Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Brozopentyl Sodium in ischemic stroke (3 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Change in NIHSS score from baseline at day 14. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
Brozopentyl Sodium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1900028334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028334.